Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05074186 · ClinicalTrials.gov registry record · NA
Assessing the Safety and Effectiveness of a Neurological Thrombectomy Medical Device for Acute Ischemic Stroke
A NA study of Ischemic Stroke, sponsored by Jacobs institute.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT05074186: Completed NA study of Ischemic Stroke, sponsored by Jacobs institute.
NCT05074186 is a NA study of Ischemic Stroke that has completed, run by Jacobs institute. The registered enrollment target is 8 participants, below the 1,464-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05074186, a NA study of Ischemic Stroke, has completed, sponsored by Jacobs institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The Jacobs Institute is participating in a Sponsor Investigator study designed to collect prospective clinical evidence to evaluate the use of a neurological thrombectomy device for clot retrieval in acute ischemic patients
Primary Outcome
The occurrence of all serious adverse device effects up to 90-days post-procedure Modified Thrombolysis in Cerebral Infarction (mTICI) score
Conditions Studied
Interventions
- DEVICE neurological thrombectomy device is an investigational device.
Study Locations (1)
New York
- kaledia Health/Buffalo General Medical Center/GVI - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-06-08 |
| Est. Completion | 2024-07-30 |
| Phase | NA |
What the finished NCT05074186 record still lists
NCT05074186 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,464-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which neurological thrombectomy device is an investigational device. is the first listed.
NCT05074186 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05074186 about?
NCT05074186 is a clinical study titled "Assessing the Safety and Effectiveness of a Neurological Thrombectomy Medical Device for Acute Ischemic Stroke". The Jacobs Institute is participating in a Sponsor Investigator study designed to collect prospective clinical evidence to evaluate the use of a neurological thrombectomy device for clot retrieval in acute ischemic patients
What is the current status of trial NCT05074186?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2021-06-08. Estimated completion is 2024-07-30.
What conditions does trial NCT05074186 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT05074186?
The interventions under investigation include: neurological thrombectomy device is an investigational device. (DEVICE).
Who is sponsoring clinical trial NCT05074186?
This trial is sponsored by Jacobs institute, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05074186 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05074186's enrollment target sits among peer trials
8 64th of 66 higher than 3 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
StrokeNet Thrombectomy Endovascular Platform
RECRUITING · NA
-
Virtual Reality Based Rehabilitation After Ischemic Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI